Showing 1331-1340 of 21414 results for "".
- First Patient Dosed in OYE Therapeutics IV Caffeine 505(b)(2) Bridging Studyhttps://reachmd.com/news/first-patient-dosed-in-oye-therapeutics-iv-caffeine-505b2-bridging-study/2486542/Key points: First patient dosed in a 505(b)(2) bridging study of OYE-101 OYE-101 is an intravenous caffeine formulation designed to accelerate recovery from anesthesia and deep sedation Study will generate human data to support a future 505(b)
- CLL Associated With Increased Skin Cancer Risk and Worse Outcomeshttps://reachmd.com/news/cll-associated-with-increased-skin-cancer-risk-and-worse-outcomes/2486544/Key points: Cohort study of more than 13,000 patients with psoriasis evaluated paradoxical eczema risk during biologic therapy Overall incidence was low (~1%), but varied by drug class IL-23 inhibitors were associated with the lowest risk comp
- First Patient Enrolled in IMPROVE-PAH Phase 3 Studyhttps://reachmd.com/news/first-patient-enrolled-in-improve-pah-phase-3-study/2486538/Key takeaways: First patient enrolled in the global, adaptive, two-part Phase 3 IMPROVE-PAH trial of IKT-001 in PAH Part A primary endpoint: change in pulmonary vascular resistance at Week 24; Part B: change in 6-minute walk distance at Week 24
- New Data Highlight How Ultrasound Imaging May Improve Safety in High-Risk Filler Injectionshttps://reachmd.com/news/new-data-highlights-how-ultrasound-imaging-may-improve-safety-in-high-risk-filler-injections/2486532/The use of dermal fillers continues to expand across aesthetic practice, accompanied by ongoing concerns regarding vascular adverse events (VAEs), including tissue necrosis and vision loss. In a recent publication in Aesthetic Plastic Surgery, investigators evaluated the role of high-res
- Antenatal MMS in Pakistan and Nigeria: Initiation and Adherencehttps://reachmd.com/news/antenatal-mms-pakistan-nigeria-initiation-adherence/2486523/Key Takeaways: Researchers report very high initiation after receipt of MMS in both Swabi and Bauchi, alongside moderate-to-high adherence patterns that varied by measurement approach and threshold. Across qualitative data, perceived benefits, trust in
- Icotrokinra Shows Sustained Skin Clearance Through 52 Weeks in Psoriasishttps://reachmd.com/news/icotrokinra-shows-sustained-skin-clearance-through-52-weeks-in-psoriasis/2486494/New 52-week data presented at the American Academy of Dermatology (AAD) 2026 Annual Meeting highlight the sustained efficacy and safety of icotro
- Early Inflammatory Signals May Precede Alopecia Areata Diagnosishttps://reachmd.com/news/early-inflammatory-signals-may-precede-alopecia-areata-diagnosis/2486446/Data from a new systematic review presented at the 2026 American Academy of Dermatology Annual Meeting indicated a consistently elevated neutrophil-to-lymphocyte ratio (NLR) in alopecia areata (AA).Investigators used data from PubMed, Embase, and Cochrane
- Inpatient Penicillin Allergy Delabeling Scales Across Hospitalshttps://reachmd.com/news/inpatient-penicillin-allergy-delabeling-scales-across-hospitals/2486501/Key Takeaways: Across 40 hospitals in 8 countries, the authors report that positive penicillin DOC results were uncommon and serious adverse events were rare within heterogeneous inpatient protocols. The authors report that bimonthly digital audit-and-
- EYLEA HD Label Update Enables Extended Dosing Intervalshttps://reachmd.com/news/eylea-hd-label-update-enables-extended-dosing-intervals/2486502/Key Takeaways: The press release reports that the FDA updated the EYLEA HD label to permit consideration of individualized dosing intervals up to ~20 weeks in selected patients after sustained response in wAMD and DME. The announcement cites 96-week da
- Pentanucleotide Instability Observed in MSI-H Colorectal Cancerhttps://reachmd.com/news/pentanucleotide-instability-observed-in-msi-h-colorectal-cancer/2486506/Key Takeaways: The authors report higher rates of combined and locus-specific Penta-C/Penta-D discordance in MSI-H versus MSS colorectal cancers. Penta-D demonstrated greater instability than Penta-C in MSI-H tumors, highlighting locus-specific variabi